ArticleEJHaem2021

Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UK.

Peter Hillmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.